Format
Sort by
Items per page

Send to

Choose Destination

Best matches for dyslipidemias AND ldl cholesterol lipoproteins:

Search results

Items: 1 to 20 of 18186

1.

Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.

Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT, Poh KK, Brudi P, Ambegaonkar B.

Atherosclerosis. 2017 Aug 21;266:158-166. doi: 10.1016/j.atherosclerosis.2017.08.013. [Epub ahead of print]

PMID:
29028484
2.

Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults.

Kang M, Kim J, Lee SY, Kim K, Yoon J, Ki H.

Korean J Fam Med. 2017 Sep;38(5):263-269. doi: 10.4082/kjfm.2017.38.5.263. Epub 2017 Sep 22.

3.

Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study.

Christensen JJ, Ulven SM, Retterstøl K, Narverud I, Bogsrud MP, Henriksen T, Bollerslev J, Halvorsen B, Aukrust P, Holven KB.

Atherosclerosis. 2017 Sep 21;266:48-57. doi: 10.1016/j.atherosclerosis.2017.09.021. [Epub ahead of print]

PMID:
28963918
4.

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?

Filippatos TD, Kei A, Elisaf MS.

Diseases. 2017 Sep 29;5(4). pii: E21. doi: 10.3390/diseases5040021. Review.

5.

Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.

Amor-Salamanca A, Castillo S, Gonzalez-Vioque E, Dominguez F, Quintana L, Lluís-Ganella C, Escudier JM, Ortega J, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P.

J Am Coll Cardiol. 2017 Oct 3;70(14):1732-1740. doi: 10.1016/j.jacc.2017.08.009.

PMID:
28958330
6.

The correlation between serum free thyroxine and regression of dyslipidemia in adult males: A 4.5-year prospective study.

Wang H, Liu A, Zhou Y, Xiao Y, Yan Y, Zhao T, Gong X, Pang T, Fan C, Zhao J, Teng W, Shan Z, Lai Y.

Medicine (Baltimore). 2017 Sep;96(39):e8163. doi: 10.1097/MD.0000000000008163.

7.

Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.

Paquette M, Dufour R, Baass A.

Can J Cardiol. 2017 Oct;33(10):1312-1318. doi: 10.1016/j.cjca.2017.07.480. Epub 2017 Jul 29.

PMID:
28941610
8.

Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.

Zhao SP, Li R, Dai W, Yu BL, Chen LZ, Huang XS.

PLoS One. 2017 Sep 21;12(9):e0184949. doi: 10.1371/journal.pone.0184949. eCollection 2017.

9.

Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia.

Bove M, Fogacci F, Cicero AFG.

Expert Opin Drug Metab Toxicol. 2017 Oct;13(10):1099-1104. doi: 10.1080/17425255.2017.1381085. Epub 2017 Sep 26. Review.

PMID:
28922021
10.

Gugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice.

Leiva A, Contreras-Duarte S, Amigo L, Sepúlveda E, Boric M, Quiñones V, Busso D, Rigotti A.

PLoS One. 2017 Sep 14;12(9):e0184280. doi: 10.1371/journal.pone.0184280. eCollection 2017.

11.

New approaches to address dyslipidemia.

Parhofer KG.

Curr Opin Lipidol. 2017 Sep 11. doi: 10.1097/MOL.0000000000000456. [Epub ahead of print]

PMID:
28902717
12.

2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.

Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD Jr, DePalma SM, Minissian MB, Orringer CE, Smith SC Jr.

J Am Coll Cardiol. 2017 Oct 3;70(14):1785-1822. doi: 10.1016/j.jacc.2017.07.745. Epub 2017 Sep 5.

PMID:
28886926
13.

LDL Cholesterol Level in Fifth Grade School Children Associates with Stature.

Pyles LA, Lilly C, Mullett C, Polak E, Elliott E, Neal WA.

J Lipid Res. 2017 Sep 4. pii: jlr.P078816. doi: 10.1194/jlr.P078816. [Epub ahead of print]

14.

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.

Ference BA, Kastelein JJP, Ginsberg HN, Chapman MJ, Nicholls SJ, Ray KK, Packard CJ, Laufs U, Brook RD, Oliver-Williams C, Butterworth AS, Danesh J, Smith GD, Catapano AL, Sabatine MS.

JAMA. 2017 Sep 12;318(10):947-956. doi: 10.1001/jama.2017.11467.

PMID:
28846118
15.

Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.

Stein EA, Dann EJ, Wiegman A, Skovby F, Gaudet D, Sokal E, Charng MJ, Mohamed M, Luirink I, Raichlen JS, Sundén M, Carlsson SC, Raal FJ, Kastelein JJP.

J Am Coll Cardiol. 2017 Aug 29;70(9):1162-1170. doi: 10.1016/j.jacc.2017.06.058.

PMID:
28838366
16.

Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial.

Kazi DS, Penko J, Coxson PG, Moran AE, Ollendorf DA, Tice JA, Bibbins-Domingo K.

JAMA. 2017 Aug 22;318(8):748-750. doi: 10.1001/jama.2017.9924. No abstract available.

PMID:
28829863
17.

Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04.

Zhang C, Li J, Wang J, Song X, Zhang J, Wu S, Hu C, Gong Z, Jia L.

BMC Complement Altern Med. 2017 Aug 14;17(1):403. doi: 10.1186/s12906-017-1892-z.

18.

Hypercholesterolemia induced cerebral small vessel disease.

Kraft P, Schuhmann MK, Garz C, Jandke S, Urlaub D, Mencl S, Zernecke A, Heinze HJ, Carare RO, Kleinschnitz C, Schreiber S.

PLoS One. 2017 Aug 10;12(8):e0182822. doi: 10.1371/journal.pone.0182822. eCollection 2017.

19.

Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.

Kim S, Yang L, Kim S, Lee RG, Graham MJ, Berliner JA, Lusis AJ, Cai L, Temel RE, Rateri DL, Lee S.

PLoS One. 2017 Aug 9;12(8):e0182566. doi: 10.1371/journal.pone.0182566. eCollection 2017.

20.

[Dyslipidemias : Diagnostics and management].

Sinning D, Landmesser U.

Herz. 2017 Aug 8. doi: 10.1007/s00059-017-4601-2. [Epub ahead of print] German.

PMID:
28791432

Supplemental Content

Loading ...
Support Center